Ultragenyx Pharmaceutical Inc. RARE
16.58 USD -0.12 (-0.72%)
Nov 12, 2026, 1:29 PM EST
16.23 Day range 16.62
12.73 52-week range 39.89
- YTD
- -27.91%
- 1 year
- -50.55%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 673.00M | 560.00M | 434.00M | 363.33M | 351.41M | |
| 673.00M | 560.00M | 434.00M | 363.33M | 351.41M | |
| 109.00M | 77.00M | 45.00M | 28.32M | 16.01M | |
| 564.00M | 483.00M | 389.00M | 335.01M | 335.40M | |
| 1.10B | 1.02B | 958.00M | 985.49M | 718.82M | |
| 750.00M | 698.00M | 648.00M | 705.79M | 497.15M | |
| 349.00M | 321.00M | 310.00M | 278.14M | 219.98M | |
| -535.00M | -536.00M | -569.00M | -650.49M | -383.42M | |
| 4.00M | 2.00M | -2.00M | 5.70M | 1.04M | |
| -575.00M | -569.00M | -607.00M | -707.42M | -454.02M | |
| -575.00M | -569.00M | -607.00M | -707.42M | -454.02M | |
| -575.00M | -569.00M | -607.00M | -707.42M | -454.02M | |
| -575.00M | -569.00M | -607.00M | -707.42M | -454.02M | |
| -5.83 | -6.29 | -8.25 | -10.12 | -6.70 | |
| -5.83 | -6.29 | -8.25 | -10.12 | -6.70 | |
| -5.83 | -6.29 | -8.25 | -10.12 | -6.70 | |
| -571.00M | -567.00M | -609.00M | -701.73M | -452.98M | |
| -571.00M | -567.00M | -609.00M | -701.73M | -452.98M | |
| 98.60M | 90.50M | 73.50M | 69.91M | 67.80M | |
| 98.60M | 90.50M | 73.50M | 69.91M | 67.80M |